医疗保健 CMO 市场、医疗保健 CMO 市场规模、医疗保健 CMO 市场份额、医疗保健 CMO 市场预测、医疗保健 CMO 市场增长、医疗保健 CMO 市场分析市场概览、增长、趋势、分析、研究报告(2023 年至 2031 年)

  • Report Code : TIPRE00003263
  • Category : Biotechnology
  • No. of Pages : 150
Buy Now

Healthcare CMO Market Forecast, Trends, Scope by 2031

Buy Now

医疗保健 CMO 市场规模预计将从 2023 年的 1,382.4 亿美元增至 2031 年的 3,852.6 亿美元。预计 2023 年至 2031 年期间,该市场的复合年增长率将达到 13.7%。不断增长的市场整合和并购的增加可能仍然是市场的主要趋势。

医疗保健 CMO 市场分析

由于生物技术和创新疗法的进步,生物制药和生物制剂领域对合同制造组织 (CMO) 服务的需求不断增长。复杂和专业分子(包括高效药物和个性化药物)的兴起增加了对具有管理复杂制造流程专业知识的 CMO 的需求。医疗保健 CMO 市场日益全球化,公司正在寻求与不同地区的 CMO 合作,以从成本效率、监管优势和进入多元化市场中受益。

医疗保健 CMO 市场概况

CMO 提供与开发、制造和包装药品、生物技术产品、医疗器械和其他医疗保健产品相关的服务。医疗保健行业正趋向于增加对 CMO 的外包。公司利用 CMO 的专业知识和技能来简化制造流程并专注于核心能力。提供灵活且可扩展的制造解决方案的 CMO 很受欢迎。适应不同的生产规模和时间表对于制药和生物技术公司至关重要。

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

医疗保健 CMO 市场:

医疗保健 CMO 市场
  • Healthcare CMO Market
    年均复合增长率(2023 - 2031)
    13.7%
  • 2023 年市场规模
    1,382.4 亿美元
  • 2031 年市场规模
    3852.6 亿美元

市场动态

增长动力
  • 制药和医疗器械制造商越来越倾向于外包
  • 老年人口不断增加,药品和医疗器械产量不断增加
未来的趋势
  • CMO 缺乏熟练的专业人员
机会
  • 发展中地区的需求不断增长

关键人物;主力;重要一员

  • 皇家帝斯曼
  • 康泰伦特公司, Inc
  • 勃林格殷格翰国际有限公司
  • Recipharm AB(出版)
  • 法雷瓦
  • 龙沙
  • 皮拉马尔企业有限公司
  • 雷迪博士实验室有限公司
  • 阿尔马克集团
  • FAMAR 医疗保健服务。

区域概况

Healthcare CMO Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Healthcare CMO Market服务
  • 药品合同制造服务
  • 医疗器械合同制造服务
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

医疗保健 CMO 市场驱动因素和机遇

老年人口不断增加,加上药品和医疗器械产量增加,有利于市场

世界各地的老年人口数量显着增加。根据联合国公布的数据,老年人口预计每年以3%的速度增长。欧洲和亚太地区60岁及以上老年人口最多。此外,预计世界人口老龄化将从2030年的14亿增加到2050年的21亿。老龄化与心血管、糖尿病、癌症等多种慢性疾病有关。因此,这些年龄段的人对治疗产品和医疗器械的需求不断增加。因此,由于全球需求不断增长,上述因素预计将推动医疗保健 CMO 市场的发展。

生物仿制药不断发展带来的增长机会

由于消费者希望获得明显的成本节约以及替代药品制造商进入成熟市场和新兴市场的机会,生物仿制药越来越受到人们的关注。技术的进步和对癌症、类风湿性关节炎等疾病的了解的改进,导致对生物仿制药和生物制剂开发的需求增加。为了满足未满足的条件,许多公司正在大力投资生物制剂制造,这将产生更高的收入回报。中国、印度、澳大利亚和韩国等新兴国家拥有最大的生物技术中心,并且由于即将到来的参与者而见证了市场的增长。因此,公司更愿意将制造服务外包给CMO,以节省生物制剂和生物仿制药开发过程中测试服务所需的内部成本和时间。这种偏爱 CMO 而不是内部制造的转变预计将增加未来几年全球 CMO 的增长机会。

医疗保健 CMO 市场报告细分分析

有助于得出医疗保健 CMO 市场分析的关键细分市场是基于服务的。

  • 根据服务,医疗保健 CMO 市场分为制药合同制造服务和医疗器械合同制造服务。制药合同制造服务进一步分为活性药物成分 (API)、最终剂型制造和包装。同样,医疗器械合同制造服务细分为外包设计、设备制造和最终产品组装。制药合同制造服务部门在 2023 年占据最大市场份额,预计在预测期内将实现最高复合年增长率。

按地域划分的医疗保健 CMO 市场份额分析

医疗保健CMO市场报告的地理范围主要分为五个地区:北美、亚太地区、欧洲、中东和非洲以及南美洲和中美洲。

北美主导了医疗保健 CMO 市场。北美医疗保健 CMO 市场的增长得益于制药、生物制药和医疗器械行业的增长、有利的条件以及监管良好的医疗保健行业。 2023年,美国占据最大市场份额。美国是制药和生物制药行业最大的市场,约占全球市场的三分之一。美国在生物制药研发活动方面被誉为世界领先者。此外,政府的支持增强了医药和生物制药的合同制造。这有助于推动公司开发公共卫生和安全所需的药物、对策和相关诊断方法。此外,复杂设备制造的增加使公司摆脱了日常担忧,并可以更加关注和努力开发公司的核心技术,从而促进该地区的市场增长。

医疗保健 CMO 市场报告范围

报告属性细节
2023年市场规模1,382.4 亿美元
2031 年市场规模3852.6亿美元
全球复合年增长率(2023 - 2031)13.7%
历史数据2021-2022
预测期2024-2031
涵盖的细分市场按服务
  • 药品合同制造服务
  • 医疗器械合同制造服务
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 皇家帝斯曼
  • 康泰伦特公司
  • 勃林格殷格翰国际有限公司
  • Recipharm AB(出版)
  • 法雷瓦
  • 龙沙
  • 皮拉马尔企业有限公司
  • 雷迪博士实验室有限公司
  • 阿尔马克集团
  • FAMAR 医疗保健服务。
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

医疗保健 CMO 市场新闻和最新动态

医疗保健 CMO 市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。下面列出了医疗保健 CMO 市场的一些发展:

  • Kühne Holding AG 已签订最终协议,将从领先的国际投资公司 BC Partners 手中收购药品合同开发和制造组织 Aenova Group。作为交易的一部分,BC Partners 的建议基金将与 Kühne Holding AG 一起进行再投资,并继续作为少数股东支持 Aenova。财务条款尚未披露。 Aenova 集团是制药和医疗保健行业世界领先的 CDMO(合同开发和制造组织)之一。 (BC Partners,新闻,2024 年 4 月)
  • 加拿大最大的制药公司 Pharmascience 宣布斥资 1.2 亿美元扩建其坎迪亚克工厂的无菌注射剂生产设施。继这一重要里程碑之后,该公司现在自豪地宣布扩大其合同开发和制造组织 (CDMO) 服务,成立了一个专门从事注射产品的新业务部门。 (Pharmascience Inc.,新闻,2024 年 2 月)
  • 丹纳赫公司宣布达成最终协议,以约 96 亿美元的现金收购私人控股的 Aldevron,丹纳赫预计将使用手头现金和/或发行商业票据为收购融资。 (丹纳赫公司,新闻稿,2021 年 6 月)

医疗保健 CMO 市场报告范围和可交付成果

《医疗保健 CMO 市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 医疗保健 CMO 市场规模以及全球、区域和国家层面涵盖的所有关键细分市场的预测
  • 医疗保健 CMO 市场趋势以及市场动态,例如驱动因素、限制因素和关键机遇
  • 详细的 PEST 和 SWOT 分析
  • 医疗保健 CMO 市场分析,涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及医疗保健 CMO 市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the healthcare CMO market in 2023?

The North America region dominated the healthcare CMO market in 2023.

What are the driving factors impacting the healthcare CMO market?

Increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs and rising geriatric population coupled with the increasing production of drugs & medical devices are the driving factors impacting the healthcare CMO market.

What are the future trends of the healthcare CMO market?

Growing market consolidation and rise in the mergers and acquisitions are likely to act as future trends for the healthcare CMO market.

Which are the leading players operating in the healthcare CMO market?

Catalent, Inc and Lonza are the leading players operating in the healthcare CMO market.

What would be the estimated value of the healthcare CMO market by 2031?

US$ 385.26 billion would be the estimated value of the healthcare CMO market by 2031.

What is the expected CAGR of the healthcare CMO market?

13.7% is the CAGR of the healthcare CMO market.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..